Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HTDS - Hard To Treat Diseases -- Ignore unavailable to you. Want to Upgrade?

To: jmhollen who wrote (164)	7/7/2005 7:04:31 PM
From: the_free_nebula	Read Replies (1) \| Respond to of 271

confusion is the name of the game there...A few said that a PR will come out in the AM...Should be interesting... TFN

To: jmhollen who wrote (164)	7/8/2005 2:43:31 PM
From: rrm_bcnu	Read Replies (5) \| Respond to of 271

John and longs: Judge Hurley ruled that Shinn had the right to cancel the sub-license agreement to HTDS OK and T-19 OK. Basically that means that although the Share exchange agreement did close and he was assessed a punitive fine of $200K, Shinn won the big prize which is the right to market Tubercin. So far I've lost $58K and have just under a million shares to get rid of. I bought another 400K shares this morning. The stock to watch is ATKJ, but I doubt I'll be investing in anything that has to do with Dr Ronald Shinn. Good luck to all here. rrm